These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15740180)

  • 21. Pregabalin: in the treatment of postherpetic neuralgia.
    Frampton JE; Foster RH
    Drugs; 2005; 65(1):111-8; discussion 119-20. PubMed ID: 15610058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregabalin: in the treatment of painful diabetic peripheral neuropathy.
    Frampton JE; Scott LJ
    Drugs; 2004; 64(24):2813-20; discussion 2821. PubMed ID: 15563250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery.
    Taylor CP; Angelotti T; Fauman E
    Epilepsy Res; 2007 Feb; 73(2):137-50. PubMed ID: 17126531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregabalin: in the treatment of generalised anxiety disorder.
    Frampton JE; Foster RH
    CNS Drugs; 2006; 20(8):685-93; discussion 694-5. PubMed ID: 16863276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience in the use of the anticonvulsant pregabalin as an add-on therapy in patients with partial epilepsy with polymorphic seizures.
    Bondarenko II
    Neurosci Behav Physiol; 2010 Feb; 40(2):163-4. PubMed ID: 20033307
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures.
    Baulac M; Leon T; O'Brien TJ; Whalen E; Barrett J
    Epilepsy Res; 2010 Sep; 91(1):10-9. PubMed ID: 20696552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregabalin: in the treatment of postherpetic neuralgia.
    McKeage K; Keam SJ
    Drugs Aging; 2009; 26(10):883-92. PubMed ID: 19761281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregabalin pharmacology and its relevance to clinical practice.
    Ben-Menachem E
    Epilepsia; 2004; 45 Suppl 6():13-8. PubMed ID: 15315511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity profile of pregabalin in rodent models of epilepsy and ataxia.
    Vartanian MG; Radulovic LL; Kinsora JJ; Serpa KA; Vergnes M; Bertram E; Taylor CP
    Epilepsy Res; 2006 Mar; 68(3):189-205. PubMed ID: 16337109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining success in clinical trials--profiling pregabalin, the newest AED.
    Ryvlin P
    Eur J Neurol; 2005 Nov; 12 Suppl 4():12-21. PubMed ID: 16144536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An open-label, add-on study of pregabalin in patients with partial seizures: a multicenter trial in Greece.
    Tsounis S; Kimiskidis VK; Kazis D; Gkiatas K; Garganis K; Karageorgiou K; Giannakodimos S; Papathanasopoulos P; Plaitakis A; Papadimitriou A; Lyras L; Emir B
    Seizure; 2011 Nov; 20(9):701-5. PubMed ID: 21775167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregabalin in neuropathic pain: a more "pharmaceutically elegant" gabapentin?
    Guay DR
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):274-87. PubMed ID: 16503325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic and pharmacodynamic profile of pregabalin and its role in the treatment of epilepsy.
    Schulze-Bonhage A
    Expert Opin Drug Metab Toxicol; 2013 Jan; 9(1):105-15. PubMed ID: 23205518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.
    Richter RW; Portenoy R; Sharma U; Lamoreaux L; Bockbrader H; Knapp LE
    J Pain; 2005 Apr; 6(4):253-60. PubMed ID: 15820913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pregabalin: new therapeutic contributions of calcium channel alpha2delta protein ligands on epilepsy and neuropathic pain].
    Horga de la Parte JF; Horga A
    Rev Neurol; 2006 Feb 16-28; 42(4):223-37. PubMed ID: 16521062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial.
    Kwan P; Brodie MJ; Kälviäinen R; Yurkewicz L; Weaver J; Knapp LE
    Lancet Neurol; 2011 Oct; 10(10):881-90. PubMed ID: 21889410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: a double-blind, randomized, placebo-controlled, multicenter trial.
    Lee BI; Yi S; Hong SB; Kim MK; Lee SA; Lee SK; Shin DJ; Kim JM; Song HK; Heo K; Lowe W; Leon T
    Epilepsia; 2009 Mar; 50(3):464-74. PubMed ID: 19222545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregabalin action at a model synapse: binding to presynaptic calcium channel alpha2-delta subunit reduces neurotransmission in mice.
    Joshi I; Taylor CP
    Eur J Pharmacol; 2006 Dec; 553(1-3):82-8. PubMed ID: 17064682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential of pregabalin in neurology, psychiatry and addiction: a qualitative overview.
    Martinotti G; Lupi M; Sarchione F; Santacroce R; Salone A; De Berardis D; Serroni N; Cavuto M; Signorelli M; Aguglia E; Valchera A; Iasevoli F; Di Giannantonio M
    Curr Pharm Des; 2013; 19(35):6367-74. PubMed ID: 23782139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures.
    Bockbrader HN; Burger P; Knapp L; Corrigan BW
    Epilepsia; 2011 Feb; 52(2):248-57. PubMed ID: 21269291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.